4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-005778
EVP, GM Gene Therapy acquired 53,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Buck Jill EVP, GM Gene Therapy | 2020-01-29 | Grant or award | +53,700 | 227,410 | D | ||
| Derivatives | |||||||
| Buck Jill EVP, GM Gene Therapy | 2020-01-29 | Grant or award · Employee Stock Option (right to buy) | +82,600 | 82,600 | D | ||
Loading xslF345X03/doc4.xml…